Psoriasis Clinical Trial

Use of Platelet-rich Plasma (PRP) Therapy in Patients With Brittle Nail Syndrome

Summary

The purpose of this study is to assess the efficacy and safety of platelet-rich plasma therapy for brittle nail syndrome

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who have been diagnosed with brittle nails
Must understand and voluntarily sign an informed consent form
Must be male or female and aged 18-95 years at time of consent
Must be able to adhere to the study visit schedule and other protocol requirements
A nail clipping with histopathology that is negative for the presence of dermatophyte infection
Patient must present with at least a score of 2 on the PGA scale.

Exclusion Criteria:

Inability of the patient to provide written informed consent for any reason.

Subject has psoriasis, lichen planus, dermatophyte infection or other confounding abnormalities that are severe enough to result in a clinically abnormal fingernail
Use of any medication within 90 days prior to start of study
Inability to abstain for nail polishes, nail gels during the study period
Subject is pregnant or planning pregnancy.

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

11

Study ID:

NCT04941807

Recruitment Status:

Completed

Sponsor:

Weill Medical College of Cornell University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Weill Cornell Medicine
New York New York, 10021, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 4

Estimated Enrollment:

11

Study ID:

NCT04941807

Recruitment Status:

Completed

Sponsor:


Weill Medical College of Cornell University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.